|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01873 VIVA BIOTECH
Nominal 
0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 383,405 | 386,051 | 77,830 | 43,181 |
| Net Cash from / (used in) Investing Activities | -- | 439,174 | (372,804) | (868,835) | (3,849,156) |
| Net Cash from / (used in) Financing Activities | -- | (429,502) | (143,196) | (653,159) | 5,307,241 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 393,077 | (129,949) | (1,444,164) | 1,501,266 |
| Cash & Cash Equivalents at beginning of period | -- | 678,569 | 800,947 | 2,308,452 | 904,091 |
| Effect of Foreign Exchange Rate Changes | -- | (35,324) | 7,571 | (63,341) | (96,905) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,036,322 | 678,569 | 800,947 | 2,308,452 |
| Remarks: | Real time quote last updated: 07/11/2024 07:44 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 116,808,000 |
| %Change | 11430.898% |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 1.753 |